255 related articles for article (PubMed ID: 34417833)
1. PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum.
Alhalabi KT; Stichel D; Sievers P; Peterziel H; Sommerkamp AC; Sturm D; Wittmann A; Sill M; Jäger N; Beck P; Pajtler KW; Snuderl M; Jour G; Delorenzo M; Martin AM; Levy A; Dalvi N; Hansford JR; Gottardo NG; Uro-Coste E; Maurage CA; Godfraind C; Vandenbos F; Pietsch T; Kramm C; Filippidou M; Kattamis A; Jones C; Øra I; Mikkelsen TS; Zapotocky M; Sumerauer D; Scheie D; McCabe M; Wesseling P; Tops BBJ; Kranendonk MEG; Karajannis MA; Bouvier N; Papaemmanuil E; Dohmen H; Acker T; von Hoff K; Schmid S; Miele E; Filipski K; Kitanovski L; Krskova L; Gojo J; Haberler C; Alvaro F; Ecker J; Selt F; Milde T; Witt O; Oehme I; Kool M; von Deimling A; Korshunov A; Pfister SM; Sahm F; Jones DTW
Acta Neuropathol; 2021 Nov; 142(5):841-857. PubMed ID: 34417833
[TBL] [Abstract][Full Text] [Related]
2. A novel LARGE1-AFF2 fusion expanding the molecular alterations associated with the methylation class of neuroepithelial tumors with PATZ1 fusions.
Tauziède-Espariat A; Chotard G; le Loarer F; Baud J; Azmani R; Dangouloff-Ros V; Boddaert N; Icher-de-Bouyn C; Gimbert E; Hasty L; Métais A; Chrétien F; Varlet P;
Acta Neuropathol Commun; 2022 Feb; 10(1):15. PubMed ID: 35115049
[TBL] [Abstract][Full Text] [Related]
3. EWSR1-PATZ1 gene fusion may define a new glioneuronal tumor entity.
Siegfried A; Rousseau A; Maurage CA; Pericart S; Nicaise Y; Escudie F; Grand D; Delrieu A; Gomez-Brouchet A; Le Guellec S; Franchet C; Boetto S; Vinchon M; Sol JC; Roux FE; Rigau V; Bertozzi AI; Jones DTW; Figarella-Branger D; Uro-Coste E
Brain Pathol; 2019 Jan; 29(1):53-62. PubMed ID: 29679497
[TBL] [Abstract][Full Text] [Related]
4. A polyphenotypic malignant paediatric brain tumour presenting a MN1-PATZ1 fusion, no epigenetic similarities with CNS High-Grade Neuroepithelial Tumour with MN1 Alteration (CNS HGNET-MN1) and related to PATZ1-fused sarcomas.
Burel-Vandenbos F; Pierron G; Thomas C; Reynaud S; Gregoire V; Duhil de Benaze G; Croze S; Chivoret N; Honavar M; Figarella-Branger D; Maurage CA; Pedeutour F; Hasselblatt M; Godfraind C
Neuropathol Appl Neurobiol; 2020 Aug; 46(5):506-509. PubMed ID: 32397004
[No Abstract] [Full Text] [Related]
5. A rare case of paediatric astroblastoma with concomitant MN1-GTSE1 and EWSR1-PATZ1 gene fusions altering management.
Chadda KR; Holland K; Scoffings D; Dean A; Pickles JC; Behjati S; Jacques TS; Trotman J; Tarpey P; Allinson K; Murray MJ;
Neuropathol Appl Neurobiol; 2021 Oct; 47(6):882-888. PubMed ID: 33534137
[TBL] [Abstract][Full Text] [Related]
6. The spectrum of rare central nervous system (CNS) tumors with EWSR1-non-ETS fusions: experience from three pediatric institutions with review of the literature.
Lopez-Nunez O; Cafferata B; Santi M; Ranganathan S; Pearce TM; Kulich SM; Bailey KM; Broniscer A; Rossi S; Zin A; Nasrallah MP; Li MM; Zhong Y; Miele E; Alaggio R; Surrey LF
Brain Pathol; 2021 Jan; 31(1):70-83. PubMed ID: 32997853
[TBL] [Abstract][Full Text] [Related]
7. Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors.
Lake JA; Donson AM; Prince E; Davies KD; Nellan A; Green AL; Mulcahy Levy J; Dorris K; Vibhakar R; Hankinson TC; Foreman NK; Ewalt MD; Kleinschmidt-DeMasters BK; Hoffman LM; Gilani A
Pediatr Blood Cancer; 2020 Jan; 67(1):e28028. PubMed ID: 31595628
[TBL] [Abstract][Full Text] [Related]
8. PATZ1-Rearranged Tumors of the Central Nervous System: Characterization of a Pediatric Series of Seven Cases.
Rossi S; Barresi S; Colafati GS; Genovese S; Tancredi C; Costabile V; Patrizi S; Giovannoni I; Asioli S; Poliani PL; Gardiman MP; Cardoni A; Del Baldo G; Antonelli M; Gianno F; Piccirilli E; Catino G; Martucci L; Quacquarini D; Toni F; Melchionda F; Viscardi E; Zucchelli M; Dal Pos S; Gatti E; Liserre R; Schiavello E; Diomedi-Camassei F; Carai A; Mastronuzzi A; Gessi M; Giannini C; Novelli A; Onetti Muda A; Miele E; Alesi V; Alaggio R
Mod Pathol; 2024 Feb; 37(2):100387. PubMed ID: 38007157
[TBL] [Abstract][Full Text] [Related]
9. Neuroepithelial tumor with EWSR1::PATZ1 fusion: A literature review.
Kim H; Lee K; Phi JH; Paek SH; Yun H; Choi SH; Park SH
J Neuropathol Exp Neurol; 2023 Oct; 82(11):934-947. PubMed ID: 37804108
[TBL] [Abstract][Full Text] [Related]
10. Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma.
Bridge JA; Sumegi J; Druta M; Bui MM; Henderson-Jackson E; Linos K; Baker M; Walko CM; Millis S; Brohl AS
Mod Pathol; 2019 Nov; 32(11):1593-1604. PubMed ID: 31189996
[TBL] [Abstract][Full Text] [Related]
11. Early ependymal tumor with MN1-BEND2 fusion: a mostly cerebral tumor of female children with a good prognosis that is distinct from classical astroblastoma.
Lehman NL
J Neurooncol; 2023 Feb; 161(3):425-439. PubMed ID: 36604386
[TBL] [Abstract][Full Text] [Related]
12. EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma.
Al-Obaidy KI; Bridge JA; Cheng L; Sumegi J; Reuter VE; Benayed R; Hameed M; Williamson SR; Hes O; Alruwaii FI; Segal JP; Wanjari P; Idrees MT; Nassiri M; Eble JN; Grignon DJ
Mod Pathol; 2021 Oct; 34(10):1921-1934. PubMed ID: 34099871
[TBL] [Abstract][Full Text] [Related]
13. Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA.
Hou Y; Pinheiro J; Sahm F; Reuss DE; Schrimpf D; Stichel D; Casalini B; Koelsche C; Sievers P; Wefers AK; Reinhardt A; Ebrahimi A; Fernández-Klett F; Pusch S; Meier J; Schweizer L; Paulus W; Prinz M; Hartmann C; Plate KH; Reifenberger G; Pietsch T; Varlet P; Pagès M; Schüller U; Scheie D; de Stricker K; Frank S; Hench J; Pollo B; Brandner S; Unterberg A; Pfister SM; Jones DTW; Korshunov A; Wick W; Capper D; Blümcke I; von Deimling A; Bertero L
Acta Neuropathol; 2019 May; 137(5):837-846. PubMed ID: 30759284
[TBL] [Abstract][Full Text] [Related]
14. Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis.
Lehman NL; Usubalieva A; Lin T; Allen SJ; Tran QT; Mobley BC; McLendon RE; Schniederjan MJ; Georgescu MM; Couce M; Dulai MS; Raisanen JM; Al Abbadi M; Palmer CA; Hattab EM; Orr BA
Acta Neuropathol Commun; 2019 Mar; 7(1):42. PubMed ID: 30876455
[TBL] [Abstract][Full Text] [Related]
15. Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.
Bogumil H; Sill M; Schrimpf D; Ismer B; Blume C; Rahmanzade R; Hinz F; Cherkezov A; Banan R; Friedel D; Reuss DE; Selt F; Ecker J; Milde T; Pajtler KW; Schittenhelm J; Hench J; Frank S; Boldt HB; Kristensen BW; Scheie D; Melchior LC; Olesen V; Sehested A; Boué DR; Abdullaev Z; Satgunaseelan L; Kurth I; Seidlitz A; White CL; Ng HK; Shi ZF; Haberler C; Deckert M; Timmer M; Goldbrunner R; Tauziède-Espariat A; Varlet P; Brandner S; Alexandrescu S; Snuderl M; Aldape K; Korshunov A; Witt O; Herold-Mende C; Unterberg A; Wick W; Pfister SM; von Deimling A; Jones DTW; Sahm F; Sievers P
Acta Neuropathol; 2023 May; 145(5):667-680. PubMed ID: 36933012
[TBL] [Abstract][Full Text] [Related]
16. Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations.
Boisseau W; Euskirchen P; Mokhtari K; Dehais C; Touat M; Hoang-Xuan K; Sanson M; Capelle L; Nouet A; Karachi C; Bielle F; Guégan J; Marie Y; Martin-Duverneuil N; Taillandier L; Rousseau A; Delattre JY; Idbaih A
Oncologist; 2019 Dec; 24(12):1584-1592. PubMed ID: 31346129
[TBL] [Abstract][Full Text] [Related]
17. Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities.
Wood MD; Tihan T; Perry A; Chacko G; Turner C; Pu C; Payne C; Yu A; Bannykh SI; Solomon DA
Brain Pathol; 2018 Mar; 28(2):192-202. PubMed ID: 28960623
[TBL] [Abstract][Full Text] [Related]
18. The clinical heterogeneity of round cell sarcomas with EWSR1/FUS gene fusions: Impact of gene fusion type on clinical features and outcome.
Tsuda Y; Zhang L; Meyers P; Tap WD; Healey JH; Antonescu CR
Genes Chromosomes Cancer; 2020 Sep; 59(9):525-534. PubMed ID: 32362012
[TBL] [Abstract][Full Text] [Related]
19. Expanding the spectrum of EWSR1-PATZ1 rearranged CNS tumors: An infantile case with leptomeningeal dissemination.
Rossi S; Barresi S; Giovannoni I; Alesi V; Ciolfi A; Colafati GS; Diomedi-Camassei F; Miele E; Cacchione A; Quacquarini D; Carai A; Tartaglia M; Giannini C; Giangaspero F; Mastronuzzi A; Alaggio R
Brain Pathol; 2021 May; 31(3):e12934. PubMed ID: 33378126
[TBL] [Abstract][Full Text] [Related]
20. BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion.
Ebrahimi A; Waha A; Schittenhelm J; Gohla G; Schuhmann MU; Pietsch T
Acta Neuropathol Commun; 2024 Apr; 12(1):60. PubMed ID: 38637838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]